ASHP to Testify at House Hearing on Compounding

Published Online: Tuesday, July 16, 2013
Follow Pharmacy_Times:
PRESS RELEASE

July 16, 2013--ASHP is scheduled to testify today at a congressional hearing on reforming the regulatory framework of pharmacy compounding.
 
Kasey K. Thompson, Pharm.D.,  M.S., ASHP vice president of policy, planning, and communications, will represent the Society at the hearing called by the Health Subcommittee of the House Energy and Commerce Committee.
 
ASHP members are encouraged to email their House of Representatives member and ask for support of compounding legislation that establishes a clear jurisdictional boundary between the FDA and state boards of pharmacy.
 
The hearing will be broadcast at 3:00 p.m. on the Committee's website.
Related Articles
With so many NAPLEX review books on the market, how can you decide which one is best?
Joseph Saseen, PharmD, from the Department of Clinical Pharmacy at the University of Colorado School of Pharmacy, discusses key points for determining blood pressure goals in patients with hypertension.
Joseph Saseen, PharmD, from the Department of Clinical Pharmacy at the University of Colorado School of Pharmacy, discusses which points in the new hypertension guidelines are particularly different from the previous guidelines.
Hae Mi Choe, PharmD, explains how metrics and tools create areas of opportunity for pharmacists.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$